Two of the nation’s most respected research institutes have completed their transaction that adds a power plant in Florida intended to accelerate the pace of biomedical discovery that benefits patients. Effective April 2, the Florida campus of Scripps Research is integrated and will now be part of the University of Florida Academic Health Center as UF Scripps Biomedical Research.
The transaction between these two leading organizations – Scripps Florida with its outstanding global reputation for biomedical research and UF Health, which has extensive expertise in clinical and biomedical research – results in a facility capable of translating biomedical discoveries into better outcomes. for patients in Florida and around the world, leaders from both organizations said.
“For patients and scientists alike, this is a memorable day. When fundamental scientific discoveries move quickly from the bench to the bedside, all of humanity sees a benefit,” said David R. Nelson, MD, senior vice president of health affairs at UF and president of UF Health. “Scripps Florida scientists have an impeccable reputation in their fields. Integrating them into UF’s research and teaching enterprise will foster many scientific and clinical breakthroughs.
Scripps Research, located in La Jolla, Calif., began working with Florida State in 2003 to establish a branch campus in Jupiter. Since then, Scripps Florida researchers have made groundbreaking discoveries that have led to hundreds of patents and numerous spin-off companies. Their work has also been heavily funded: The roughly 45 researchers at Scripps Florida make up one of the top research centers supported by the state’s National Institutes of Health. Discussions to integrate UF and the Scripps Florida campus began in mid-2021 and were formalized in November. Operations at Scripps Research’s main campus are unaffected by the transition, and the more than 175 active faculty continue to pursue critical scientific discovery and drug development.
“Our Jupiter campus has specialized resources that enable drug discovery that is more generally associated with the pharmaceutical industry and all of this happens in a not-for-profit academic setting,” said Patrick Griffin, Ph.D., Chief Scientific Officer. and professor of molecular medicine. for UF Scripps Biomedical Research. “Our new connection to UF Health’s clinical and scientific expertise provides an exceptional opportunity to accelerate scientific discovery for the benefit of those in need.”
With the integration of the former Scripps Research campus into UF, UF Scripps Biomedical Research combines the clinical expertise of a top 5 public university with the creative energies of one of the world’s leading biomedical research organizations, said Nelson.
“Together, UF Health and UF Scripps Biomedical Research can more effectively combat disease threats, address persistent medical challenges, and create new science education opportunities. Ultimately, this guarantees generations of people in Florida and elsewhere a brighter, healthier future,” Nelson said.
“UF Scripps Biomedical Research is poised to build on a strong legacy of innovation at the University of Florida and Scripps Research, translating the art and science of discovery into enormous benefits for the State of Florida. , the nation and the world,” Mori said. Hosseini, chairman of the UF board of directors. “The amazing discoveries that I know will come from this team will bring hope and healing to millions of people.”
UF President Kent Fuchs said UF Scripps Biomedical Research is ushering in a new era of even more scientific collaborations that will also include other institutions in the state university system such as Florida International and Florida Atlantic universities. . Recent collaborations between UF and FAU have included research on Alzheimer’s disease and work on emerging trends in drug abuse.
“I’m really excited about the prospect of former Scripps Florida faculty joining UF. The breakthroughs our combined efforts will bring will exemplify one of our most important missions: to put science at the service of some of the world’s most pressing problems,” said Fuchs.
UF Scripps Biomedical Research will also build on Scripps Research’s longstanding commitment to training future generations of research scientists. The Florida branch of Skaggs Graduate School of Chemical and Biological Sciences continues to operate as part of Scripps Research’s bicoastal graduate program, with continued support from UF Health. It has approximately 85 doctoral students taught by faculty members in Florida and works closely with the graduate faculty at Scripps Research in California.
Additionally, UF Scripps Biomedical Research will launch a new program to foster scientific careers among recent college graduates. The Post-Baccalaureate Research and Education Program, or PREP, is an immersive, year-long research experience that equips recent bachelor’s graduates with additional academic and laboratory skills in preparation for applying to a high-calibre, research-oriented doctorate. programs. The deadline to apply to join the first PREP class is April 15.
UF Scripps Biomedical Research maintains its presence on the three-building, 30-acre campus in Jupiter, Florida, which opened in 2009. Scientists there joined UF faculty while maintaining an additional affiliate title of Scripps Research.
The Scripps Florida-UF Health integration was facilitated by Herbert Wertheim, a UF alumnus, Scripps Research board member, and honorary president of UF’s Herbert Wertheim College of Engineering.
Media contact: Doug Bennett at firstname.lastname@example.org or 813-786-2164